Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Income from Continuing Operations (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Income from Continuing Operations for 2 consecutive years, with 24138000.0 as the latest value for Q4 2023.

  • On a quarterly basis, Income from Continuing Operations rose 9.77% to 24138000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was 75402000.0, a 28.62% increase, with the full-year FY2024 number at 49769000.0, up 28.87% from a year prior.
  • Income from Continuing Operations was 24138000.0 for Q4 2023 at LENZ Therapeutics, down from 23940000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 12616000.0 in Q1 2023 to a low of 26776000.0 in Q2 2022.